Xilio Therapeutics, Inc.
Pharmaceutical Preparations
828 Winter Street, Waltham, MA, 02451 Insider Ownership
Above 5% Ownership
- 13F-NT
- 3
- SC 13D/A
- SC 13G
- SC 13D
- SC 13G/A
- SC 13G/A
- SC 13G/A
- 3
- SC 13G/A
- 13F-HR
- SC 13G
- SC 13G
- 13F-HR
- 13F-HR
- SC 13D/A
- 4
- SC 13D/A
- SC 13G
- SC 13G/A
- SC 13G/A
- SC 13G
- SC 13G/A
- SC 13G
- SC 13G/A
Curran Daniel J.
Curran Daniel J.
17 Jun 24
Curran Daniel J.
21 Oct 21
Humphrey Rachel
Humphrey Rachel
28 Mar 23
Humphrey Rachel
15 Aug 22
Humphrey Rachel
15 Aug 22
Humphrey Rachel
05 Mar 18
Humphrey Rachel
26 Jan 18
Luptakova Katarina
Luptakova Katarina
03 May 24
Luptakova Katarina
03 Jan 24
Luptakova Katarina
07 Sep 23
Luptakova Katarina
07 Sep 23
Lynch Daniel
Lynch Daniel
17 Nov 21
Lynch Daniel
26 Jun 20
Lynch Daniel
25 Jun 18
Lynch Daniel
08 Jun 17
Lynch Daniel
23 Mar 04
Bain Capital Life Sciences Fund Ii, L.p.
14 Aug 23
Bain Capital Life Sciences Investors, Llc
05 Dec 22
Amended Statement Of Beneficial Ownership Of More Than 5%.
24 Sep 21
14 Dec 20
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
17 Apr 20
Gkcc, Llc
Chudnovsky Yekaterina
27 Sep 24
27 Sep 24
Chudnovsky Yekaterina
02 Jul 24
Amended Statement Of Beneficial Ownership Of More Than 5%.
20 Mar 24
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
14 Jun 23
Sv7 Impact Medicine Fund Lp
Sv7 Impact Medicine Fund Lp
03 Nov 21
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
03 Nov 21
Sv7 Impact Medicine Fund Lp
28 Oct 21
Sv7 Impact Medicine Fund Lp
21 Oct 21
Notice Of An Exempt Offering Of Securities Under Regulation D.
25 Jun 19
Rivervest Venture Fund Iv, L.p.
Amended Statement Of Beneficial Ownership Of More Than 5%.
01 Dec 22
Rivervest Venture Fund Iv, L.p.
21 Oct 21
Amended Statement Of Beneficial Ownership Of More Than 5%.
22 Dec 20
Rivervest Venture Fund Iii, L.p.
08 Oct 20
Amended Notice Of An Exempt Offering Of Securities Under Regulation D.
09 Oct 18
Rock Springs Capital Management Lp
14 Feb 24
14 Feb 23
15 Feb 22
Rock Springs Capital Management Lp
10 Jan 22
14 Feb 18
Mrl Ventures Fund Llc
10 Apr 23
08 Feb 22
Mrl Ventures Fund Llc
03 Jul 18
Mrl Ventures Fund Llc
27 Jun 18
Octagon Capital Advisors Lp
Quarterly Holdings Report
14 Nov 24
11 Oct 24
03 Jul 24
Quarterly Holdings Report
14 Nov 23
Quarterly Holdings Report
14 Aug 23
Gilead Sciences, Inc.
Milligan John F
08 Jun 16
Madigan John W
13 May 11
Alton Gregg H
10 Mar 10
Wilson Gayle E
11 May 07
Alton Gregg H
27 Jan 06
Flynn James E
14 Nov 24
10 Feb 20
16 Apr 15
Flynn James E
31 Dec 08
Flynn James E
24 May 06
Ra Capital Management, L.p.
Amended Statement Of Beneficial Ownership Of More Than 5%.
13 Nov 24
Ra Capital Management, L.p.
25 Jul 23
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Nov 22
16 Feb 21
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 14
Atlas Venture Fund Xi, L.p.
14 Nov 24
Atlas Venture Fund Xi, L.p.
16 Jan 24
Report With Error Fetching Owner Name
07 Nov 23
11 Feb 22
Atlas Venture Fund Xi, L.p.
19 Jun 19
Takeda Pharmaceutical Co Ltd
Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.
07 Jun 24
Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.
29 May 24
Amended Statement Of Beneficial Ownership Of More Than 5%.
01 Apr 24
Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.
14 Jun 19
08 Feb 19
Fmr Llc
09 Feb 22
14 Feb 14
16 Feb 10
10 Nov 03
11 Feb 97